iTeos Therapeutics バランスシートの健全性
財務の健全性 基準チェック /66
iTeos Therapeuticsの総株主資本は$631.7M 、総負債は$0.0で、負債比率は0%となります。総資産と総負債はそれぞれ$723.1Mと$91.4Mです。
主要情報
0%
負債資本比率
US$0
負債
| インタレスト・カバレッジ・レシオ | n/a |
| 現金 | US$488.71m |
| エクイティ | US$631.69m |
| 負債合計 | US$91.39m |
| 総資産 | US$723.08m |
財務の健全性に関する最新情報
Is iTeos Therapeutics (NASDAQ:ITOS) In A Good Position To Deliver On Growth Plans?
Aug 11
We Think iTeos Therapeutics (NASDAQ:ITOS) Can Afford To Drive Business Growth
Aug 24We Think iTeos Therapeutics (NASDAQ:ITOS) Can Easily Afford To Drive Business Growth
Feb 07Recent updates
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year
Nov 15iTeos Therapeutics: ESMO Data Showing Signs Of A Real Win For TIGIT
Sep 15Is iTeos Therapeutics (NASDAQ:ITOS) In A Good Position To Deliver On Growth Plans?
Aug 11iTeos Therapeutics: Rippling Waves Of TIGIT Pessimism
Jul 09iTeos Therapeutics, Inc. (NASDAQ:ITOS) Looks Inexpensive But Perhaps Not Attractive Enough
Jan 25iTeos: Readouts From TIGIT And Adenosine Pathway Inhibitors Makes This A Must Watch
Jan 10Industry Analysts Just Upgraded Their iTeos Therapeutics, Inc. (NASDAQ:ITOS) Revenue Forecasts By 16%
May 13Investors Give iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares A 25% Hiding
Mar 21The Consensus EPS Estimates For iTeos Therapeutics, Inc. (NASDAQ:ITOS) Just Fell Dramatically
Aug 12iTeos Therapeutics GAAP EPS of $0.16 misses by $1.04
Aug 10iTeos Therapeutics: Too Many Unknowns
Jul 27News Flash: Analysts Just Made A Captivating Upgrade To Their iTeos Therapeutics, Inc. (NASDAQ:ITOS) Forecasts
May 11Rainbows and Unicorns: iTeos Therapeutics, Inc. (NASDAQ:ITOS) Analysts Just Became A Lot More Optimistic
Nov 25We Think iTeos Therapeutics (NASDAQ:ITOS) Can Afford To Drive Business Growth
Aug 24iTeos Therapeutics: My Calculations Suggest Q3 Earnings Will Exceed $10 Per Share
Aug 15GlaxoSmithKline - iTeos deal intensifies competition in anti-TIGIT space: Piper Sandler
Jun 15We Think iTeos Therapeutics (NASDAQ:ITOS) Can Easily Afford To Drive Business Growth
Feb 07Is iTeos Therapeutics, Inc. (NASDAQ:ITOS) Popular Amongst Institutions?
Dec 16
iTeos Therapeutics EPS misses by $0.11
Nov 12財務状況分析
短期負債: ITOSの 短期資産 ( $544.9M ) が 短期負債 ( $36.8M ) を超えています。
長期負債: ITOSの短期資産 ( $544.9M ) が 長期負債 ( $54.6M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: ITOSは負債がありません。
負債の削減: ITOS過去 5 年間負債を抱えていません。
債務返済能力: ITOSには負債がないため、営業キャッシュフロー でカバーする必要はありません。
インタレストカバレッジ: ITOSには負債がないため、利息支払い の負担は問題になりません。